Cachet Pharmaceutical Co., Ltd.
Symbool: 002462.SZ
SHZ
12.28
CNYMarktprijs vandaag
14.3690
Koers/Winst Verhouding
0.7993
Koers/Winst Groei Verhouding
3.58B
MRK Kapitalisatie
- 0.02%
DIV Rendement
Cachet Pharmaceutical Co., Ltd. (002462-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 10532.55 | 2885.6 | 2183.7 | 2338.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 0.59 | 0.1 | 0.2 | 0.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 38852.37 | 9187.4 | 9948 | 8640.8 | |||||||||||||||||
balance-sheet.row.inventory | 10431.64 | 2561.7 | 2692.3 | 2185.4 | |||||||||||||||||
balance-sheet.row.other-current-assets | 630.57 | 156.7 | 171.6 | 120.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 60447.13 | 15630.5 | 14995.6 | 13285.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2752.52 | 679.7 | 735.9 | 850.3 | |||||||||||||||||
balance-sheet.row.goodwill | 1983.55 | 475.9 | 515.9 | 562.4 | |||||||||||||||||
balance-sheet.row.intangible-assets | 142.71 | 35.6 | 35.8 | 36.6 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2126.27 | 511.4 | 551.7 | 599 | |||||||||||||||||
balance-sheet.row.long-term-investments | 7.78 | 1.7 | 2.3 | 2.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 374.33 | 93 | 68.1 | 52.6 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 789.85 | 204.4 | 203 | 148.2 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 6050.75 | 1490.3 | 1561 | 1652.3 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.account-payables | 23067.09 | 5858.1 | 5319.5 | 4442.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 14121.28 | 3842.7 | 4068 | 3774.5 | |||||||||||||||||
balance-sheet.row.tax-payables | 394.27 | 115.5 | 96.8 | 99.8 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
Deferred Revenue Non Current | -4.3 | -4.3 | 0 | 0 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 30.66 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 130.84 | 53 | 732.8 | 34 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 811.74 | 180.2 | 220 | 259.2 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 781.08 | 175.9 | 208.8 | 229.2 | |||||||||||||||||
balance-sheet.row.total-liab | 42070.44 | 11029.3 | 10635 | 9281 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 1166.83 | 291.7 | 291.7 | 291.7 | |||||||||||||||||
balance-sheet.row.retained-earnings | 9684.4 | 2430.6 | 2268.1 | 2079.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3516.49 | 0 | 240 | 237.6 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2556.4 | 1518.2 | 1278.2 | 1278.2 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 16924.12 | 4240.5 | 4078 | 3886.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66497.88 | 17120.9 | 16556.6 | 14937.5 | |||||||||||||||||
balance-sheet.row.minority-interest | 7503.32 | 1851 | 1843.6 | 1770 | |||||||||||||||||
balance-sheet.row.total-equity | 24427.44 | 6091.5 | 5921.6 | 5656.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66497.88 | - | - | - | |||||||||||||||||
Total Investments | 8.37 | 1.7 | 2.4 | 2.5 | |||||||||||||||||
balance-sheet.row.total-debt | 14902.36 | 4018.7 | 4276.8 | 4003.8 | |||||||||||||||||
balance-sheet.row.net-debt | 4370.4 | 1133.2 | 2093.2 | 1665.6 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 257.86 | 468.3 | 601.9 | 590.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 168.35 | 226.7 | 201.1 | 175.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 34.3 | 3.5 | -0.3 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -528.8 | -1216.3 | -133.8 | -47.7 | ||||||||||||||||
cash-flows.row.account-receivables | -601.58 | -2437.7 | -655.1 | -699 | ||||||||||||||||
cash-flows.row.inventory | 72.78 | -510.7 | -179.8 | 183.5 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 1766.3 | 704.7 | 467.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 1271.58 | 357.8 | 243.9 | 395.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1168.99 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.acquisitions-net | 50.76 | -1.6 | 59.2 | 1.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 3.92 | 0 | -16.2 | -42 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -25.33 | 10.9 | 2.3 | 1 | ||||||||||||||||
cash-flows.row.other-investing-activites | 31.44 | 3.8 | -55.5 | 4.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -168.68 | -175.4 | -257.1 | -293.5 | ||||||||||||||||
cash-flows.row.debt-repayment | -3431.74 | -4619.6 | -3975.2 | -4948.4 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -207.44 | -282.3 | -242.7 | -289.1 | ||||||||||||||||
cash-flows.row.other-financing-activites | 1938.41 | 4739.1 | 3884.8 | 4864 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -753.17 | -162.8 | -333.1 | -373.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -0.7 | -0.4 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 247.14 | -501.7 | 322.2 | 447.4 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 8914.64 | 1699.3 | 2201 | 1878.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 8667.5 | 2201 | 1878.8 | 1431.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 1168.99 | -163.4 | 913.1 | 1114.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -197.7 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.free-cash-flow | 971.3 | -352 | 666.2 | 856.9 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 30683.14 | 29996.2 | 26219.8 | 25625.6 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 28755.67 | 28018.5 | 24112.2 | 23484.9 | |||||||||||||||||
income-statement-row.row.gross-profit | 1927.46 | 1977.7 | 2107.6 | 2140.8 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 61.72 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.operating-expenses | 1023.97 | 1072.1 | 1162 | 1103.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 29779.65 | 29090.6 | 25274.3 | 24588.6 | |||||||||||||||||
income-statement-row.row.interest-income | 189.45 | 31.1 | -22.4 | 17.1 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 678.23 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.53 | -12 | 263.7 | 234.2 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -217.24 | -350.4 | -292 | -6.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 73.91 | 155.4 | 175.3 | 164.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 281.99 | 202.1 | 226.7 | 408.3 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 904.8 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 573.55 | 556.4 | 936.9 | 830.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 583.96 | 555.3 | 644.9 | 824 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 187.67 | 178.7 | 176.6 | 222.1 | |||||||||||||||||
income-statement-row.row.net-income | 257.86 | 250.1 | 468.3 | 601.9 |
Vaak gestelde vragen
Wat is Cachet Pharmaceutical Co., Ltd. (002462.SZ) totale activa?
Cachet Pharmaceutical Co., Ltd. (002462.SZ) totale activa is 17120851592.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 15651563096.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.063.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.008.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.019.
Wat is Cachet Pharmaceutical Co., Ltd. (002462.SZ) nettowinst (netto-inkomen)?
De nettowinst is 250060041.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 4018688843.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 1072054997.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 2853572169.000.